We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Danaher (DHR) Beats on Q4 Earnings & Revenues, Guides Well
Read MoreHide Full Article
Danaher Corporation (DHR - Free Report) is a global conglomerate that designs, manufactures and markets diverse lines of professional, medical, industrial, commercial and consumer products.
DHR’s tried and tested business model – the Danaher Business System (‘DBS’) – has proved to be the fundamental growth driver, fueling revenue, margins, cash flow and earnings improvement. Moreover, DHR’s previously completed acquisitions have also been driving its top-line growth significantly. These strategic buyouts along with positive industry trends are expected to act as tailwinds.
However, DHR has faced stunted organic revenue growth in its dental segment, mainly attributable to weakness in higher-margin traditional consumables business. Moreover, softness in industrial markets in China, North America, Latin America and the Middle East has been severely impacting the company’s business.
DHR has consistently beaten earnings in the trailing four quarters, with an average positive surprise of 2.6%.
Revenue: Revenues of $5,085.7 million topped the Zacks Consensus Estimate of $4,972 million.
Key Stats: Concurrent with the earnings release, provided its guidance for full-year 2018. The company projects adjusted earnings per share in the range of $4.25–$4.35. Overall, the company reported impressive key metrics largely driven by its effective business model, the DBS, which focuses on three critical areas -- quality, delivery, and cost & innovation.
Stock Price: DHR shares were inactive following the release. It would be interesting to see how the market reacts to the results during the trading session today.
Check back later for our full write up on this DHR earnings report later!
Don’t Even Think About Buying Bitcoin Until You Read This
The most popular cryptocurrency skyrocketed last year, giving some investors the chance to bank 20X returns or even more. Those gains, however, came with serious volatility and risk. Bitcoin sank 25% or more 3 times in 2017.
Zacks’ has just released a new Special Report to help readers capitalize on the explosive profit potential of Bitcoin and the other cryptocurrencies with significantly less volatility than buying them directly.
Image: Bigstock
Danaher (DHR) Beats on Q4 Earnings & Revenues, Guides Well
Danaher Corporation (DHR - Free Report) is a global conglomerate that designs, manufactures and markets diverse lines of professional, medical, industrial, commercial and consumer products.
DHR’s tried and tested business model – the Danaher Business System (‘DBS’) – has proved to be the fundamental growth driver, fueling revenue, margins, cash flow and earnings improvement. Moreover, DHR’s previously completed acquisitions have also been driving its top-line growth significantly. These strategic buyouts along with positive industry trends are expected to act as tailwinds.
However, DHR has faced stunted organic revenue growth in its dental segment, mainly attributable to weakness in higher-margin traditional consumables business. Moreover, softness in industrial markets in China, North America, Latin America and the Middle East has been severely impacting the company’s business.
DHR has consistently beaten earnings in the trailing four quarters, with an average positive surprise of 2.6%.
Currently, DHR has a Zacks Rank #3 (Buy) but that could change following its fourth-quarter 2017 earnings report which has just released. You can see the complete list of today’s Zacks #1(Strong Buy) Rank stocks here.
We have highlighted some of the key details from the just-released announcement below:
Earnings: Adjusted earnings per share for the fourth-quarter 2017 came in at $1.19, which beat the Zacks Consensus Estimate of $1.16.
Danaher Corporation Price and EPS Surprise
Danaher Corporation Price and EPS Surprise | Danaher Corporation Quote
Revenue: Revenues of $5,085.7 million topped the Zacks Consensus Estimate of $4,972 million.
Key Stats: Concurrent with the earnings release, provided its guidance for full-year 2018. The company projects adjusted earnings per share in the range of $4.25–$4.35. Overall, the company reported impressive key metrics largely driven by its effective business model, the DBS, which focuses on three critical areas -- quality, delivery, and cost & innovation.
Stock Price: DHR shares were inactive following the release. It would be interesting to see how the market reacts to the results during the trading session today.
Check back later for our full write up on this DHR earnings report later!
Don’t Even Think About Buying Bitcoin Until You Read This
The most popular cryptocurrency skyrocketed last year, giving some investors the chance to bank 20X returns or even more. Those gains, however, came with serious volatility and risk. Bitcoin sank 25% or more 3 times in 2017.
Zacks’ has just released a new Special Report to help readers capitalize on the explosive profit potential of Bitcoin and the other cryptocurrencies with significantly less volatility than buying them directly.
See 4 crypto-related stocks now >>